<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32098238</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>11</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>11</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Feb</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Alterations in the Nervous System and Gut Microbiota after <i>β</i>-Hemolytic Streptococcus Group A Infection-Characteristics and Diagnostic Criteria of PANDAS Recognition.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1476</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21041476</ELocationID>
        <Abstract>
          <AbstractText>The objective of this paper is to review and summarize conclusions from the available literature regarding Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS). The authors have independently reviewed articles from 1977 onwards, primarily focusing on the etiopathology, symptoms, differentiation between similar psychiatric conditions, immunological reactions, alterations in the nervous system and gut microbiota, genetics, and the available treatment for PANDAS. Recent research indicates that PANDAS patients show noticeable alterations within the structures of the central nervous system, including caudate, putamen, globus pallidus, and striatum, as well as bilateral and lentiform nuclei. Likewise, the presence of autoantibodies that interact with basal ganglia was observed in PANDAS patients. Several studies also suggest a relationship between the presence of obsessive-compulsive disorders like PANDAS and alterations to the gut microbiota. Further, genetic predispositions-including variations in the <i>MBL</i> gene and T<i>NF-α</i>-seem to be relevant regarding PANDAS syndrome. Even though the literature is still scarce, the authors have attempted to provide a thorough insight into the PANDAS syndrome, bearing in mind the diagnostic difficulties of this condition.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baj</LastName>
            <ForeName>Jacek</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-1372-8987</Identifier>
            <AffiliationInfo>
              <Affiliation>Chair and Department of Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sitarz</LastName>
            <ForeName>Elżbieta</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0001-7503-1838</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Medical University of Lublin, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Forma</LastName>
            <ForeName>Alicja</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-8714-7627</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Medical University of Lublin, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wróblewska</LastName>
            <ForeName>Katarzyna</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>North London Forensic Service, Chase Farm Hospital, 127 The Ridgeway, Enfield, Middlesex EN2 8JL, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karakuła-Juchnowicz</LastName>
            <ForeName>Hanna</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Chair and 1st Department of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, Gluska Street 1, 20-439 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Neuropsychiatry, Medical University of Lublin, Gluska Street 1, 20-439 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001479" MajorTopicYN="N">Basal Ganglia</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009771" MajorTopicYN="Y">Obsessive-Compulsive Disorder</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013290" MajorTopicYN="Y">Streptococcal Infections</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PANDAS</Keyword>
        <Keyword MajorTopicYN="N">PANS</Keyword>
        <Keyword MajorTopicYN="N">diagnostic criteria</Keyword>
        <Keyword MajorTopicYN="N">gut microbiota</Keyword>
        <Keyword MajorTopicYN="N">nervous system</Keyword>
        <Keyword MajorTopicYN="N">obsessive-compulsive disorder</Keyword>
        <Keyword MajorTopicYN="N">pediatric acute-onset neuropsychiatric syndrome</Keyword>
        <Keyword MajorTopicYN="N">pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections</Keyword>
        <Keyword MajorTopicYN="N">psychiatry</Keyword>
        <Keyword MajorTopicYN="N">β-hemolytic Streptococcus group A</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32098238</ArticleId>
        <ArticleId IdType="pmc">PMC7073132</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms21041476</ArticleId>
        <ArticleId IdType="pii">ijms21041476</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Anjos L.M.M., Marcondes M.B., Lima M.F., Mondelli A.L., Okoshi M.P. Streptococcal acute pharyngitis. Rev. Soc. Bras. Med. Trop. 2014;47:409–413. doi: 10.1590/0037-8682-0265-2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/0037-8682-0265-2013</ArticleId>
            <ArticleId IdType="pubmed">25229278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ivaska L., Niemela J., Lempainen J., Osterback R., Waris M., Vuorinen T., Hytonen J., Rantakokko-Jalava K., Peltola V. Aetiology of febrile pharyngitis in children: Potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection. J. Infect. 2017;74:385–392. doi: 10.1016/j.jinf.2017.01.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2017.01.002</ArticleId>
            <ArticleId IdType="pmc">PMC7127312</ArticleId>
            <ArticleId IdType="pubmed">28077283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bisno A.L. Acute Pharyngitis. N. Engl. J. Med. 2001;344:205–211. doi: 10.1056/NEJM200101183440308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM200101183440308</ArticleId>
            <ArticleId IdType="pubmed">11172144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soderholm A.T., Barnett T.C., Sweet M.J., Walker M.J. Group a streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies. J. Leukoc. Biol. 2017;103:193–213. doi: 10.1189/jlb.4MR0617-227RR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.4MR0617-227RR</ArticleId>
            <ArticleId IdType="pubmed">28951419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaikh N., Swaminathan N., Hooper E.G. Accuracy and precision of the signs and symptoms of streptococcal pharyngitis in children: A systematic review. J. Pediatr. 2012;160:487–493. doi: 10.1016/j.jpeds.2011.09.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpeds.2011.09.011</ArticleId>
            <ArticleId IdType="pubmed">22048053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shulman S.T., Tanz R.R. Group a streptococcal pharyngitis and immune-mediated complications: From diagnosis to management. Expert Rev. Anti Infect. Ther. 2010;8:137–150. doi: 10.1586/eri.09.134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/eri.09.134</ArticleId>
            <ArticleId IdType="pubmed">20109044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker M.J., Barnett T.C., McArthur J.D., Cole J.N., Gillen C.M., Henningham A., Sriprakash K.S., Sanderson-Smith M.L., Nizet V. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin. Microbiol. Rev. 2014;27:264–301. doi: 10.1128/CMR.00101-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00101-13</ArticleId>
            <ArticleId IdType="pmc">PMC3993104</ArticleId>
            <ArticleId IdType="pubmed">24696436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dietrich D.E., Zhang Y., Bode L., Munte T.F., Hauser U., Schmorl P., Richter-Witte C., Godecke-Koch T., Feutl S., Schramm J., et al.  Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive-compulsive disorder. Mol. Psychiatry. 2005;10:519–520. doi: 10.1038/sj.mp.4001645.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4001645</ArticleId>
            <ArticleId IdType="pubmed">15668719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller N., Riedel M., Blendinger C., Oberle K., Jacobs E., Abele-Horn M. Mycoplasma pneumoniae infection and Tourette’s syndrome. Psychiatry Res. 2004;129:119–125. doi: 10.1016/j.psychres.2004.04.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psychres.2004.04.009</ArticleId>
            <ArticleId IdType="pubmed">15590039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuo M., Tsuchiya K., Hamasaki Y., Singer H.S. Restless legs syndrome: Association with streptococcal or Mycoplasma infection. Pediatr. Neurol. 2004;31:119–121. doi: 10.1016/j.pediatrneurol.2003.12.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2003.12.009</ArticleId>
            <ArticleId IdType="pubmed">15301831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leon J., Hommer R., Grant P., Farmer C., D’Souza P., Kessler R., Williams K., Leckman J.F., Swedo S. Longitudinal outcomes of children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) Eur. Child Adolesc. Psychiatry. 2018;27:637–643. doi: 10.1007/s00787-017-1077-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00787-017-1077-9</ArticleId>
            <ArticleId IdType="pubmed">29119300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carapetis J.R., Beaton A., Cunningham M.W., Guilherme L., Karthikeyan G., Mayosi B.M., Sable C., Steer A., Wilson N., Wyber R., et al.  Acute rheumatic fever and rheumatic heart disease. Nat. Rev. Dis. Primers. 2016;2:1–24. doi: 10.1038/nrdp.2015.84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrdp.2015.84</ArticleId>
            <ArticleId IdType="pmc">PMC5810582</ArticleId>
            <ArticleId IdType="pubmed">27188830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coffey P.M., Ralph A.P., Krause V.L. The role of social determinants of health in the risk and prevention of group a streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review. PLoS Negl. Trop. Dis. 2018;12:1–22. doi: 10.1371/journal.pntd.0006577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0006577</ArticleId>
            <ArticleId IdType="pmc">PMC6016946</ArticleId>
            <ArticleId IdType="pubmed">29897915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gewitz M.H., Baltimore R.S., Tani L.Y., Sable C.A., Shulman S.T., Carapetis J., Remenyi B., Taubert K.A., Bolger A.F., Beerman L., et al.  Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography. Circulation. 2015;131:1806–1818. doi: 10.1161/CIR.0000000000000205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000205</ArticleId>
            <ArticleId IdType="pubmed">25908771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karthikeyan G., Guilherme L. Acute rheumatic fever. Lancet. 2018;392:161–174. doi: 10.1016/S0140-6736(18)30999-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(18)30999-1</ArticleId>
            <ArticleId IdType="pubmed">30025809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webb R.H., Grant C., Harnden A. Acute rheumatic fever. BMJ. 2015;351:h3443. doi: 10.1136/bmj.h3443.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.h3443</ArticleId>
            <ArticleId IdType="pubmed">26175053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carapetis J.R., Currie B.J., Mathews J.D. Cumulative incidence of rheumatic fever in an endemic region: A guide to the susceptibility of the population? Epidemiol. Infect. 2000;124:239–244. doi: 10.1017/S0950268800003514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268800003514</ArticleId>
            <ArticleId IdType="pmc">PMC2810907</ArticleId>
            <ArticleId IdType="pubmed">10813149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guilherme L., Kalil J. Rheumatic fever and rheumatic heart disease: Cellular mechanisms leading autoimmune reactivity and disease. J. Clin. Immunol. 2010;30:17–23. doi: 10.1007/s10875-009-9332-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10875-009-9332-6</ArticleId>
            <ArticleId IdType="pubmed">19802690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia A.F., Yamaga K.M., Shafer L.A., Bollt O., Tam E.K., Cunningham M.W., Kurahara D.K. Cardiac myosin epitopes recognized by autoantibody in acute and convalescent rheumatic fever. Pediatr. Infect. Dis. J. 2016;35:1021–1026. doi: 10.1097/INF.0000000000001235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001235</ArticleId>
            <ArticleId IdType="pmc">PMC4987259</ArticleId>
            <ArticleId IdType="pubmed">27273689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez-Vigil A., Cruz L.F.D.L., Brander G., Isomura K., Gromark C., Mataix-Cols D. The link between autoimmune diseases and obsessive-compulsive and tic disorders: A systematic review. Neurosci. Biobehav. Rev. 2016;71:542–562. doi: 10.1016/j.neubiorev.2016.09.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2016.09.025</ArticleId>
            <ArticleId IdType="pubmed">27687817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asbahr F.R., Negrao A.B., Gentil V., Zanetta D.M., Paz J.A.D., Marques-Dias M.J., Kiss M.H. Obsessive-Compulsive and Related Symptoms in Children and Adolescents with Rheumatic Fever With and Without Chorea: A Prospective 6-Month Study. Am. J. Psychiatry. 1998;155:1122–1124. doi: 10.1176/ajp.155.8.1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/ajp.155.8.1122</ArticleId>
            <ArticleId IdType="pubmed">9699708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grzanka K., Pieczyrak R., Kotulska A., Kucharz E. Zmiany dotyczace ukladu nerwowego u chorych na goraczke reumatyczna Neurological involvement in patients with rheumatic fever. Reumatologia/Rheumatology. 2005;43:211–215.</Citation>
        </Reference>
        <Reference>
          <Citation>Punukollu M., Mushet N., Linney M., Hennessy C., Morton M. Neuropsychiatric manifestations of Sydenham’s chorea: A systematic review. Dev. Med. Child Neurol. 2016;58:16–28. doi: 10.1111/dmcn.12786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/dmcn.12786</ArticleId>
            <ArticleId IdType="pubmed">25926089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galvin J.E., Hemric M.E., Ward K., Cunningham M.W. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J. Clin. Investig. 2000;106:217–224. doi: 10.1172/JCI7132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI7132</ArticleId>
            <ArticleId IdType="pmc">PMC314302</ArticleId>
            <ArticleId IdType="pubmed">10903337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham M.W. Rheumatic Fever, Autoimmunity, and Molecular Mimicry: The Streptococcal Connection. Int. Rev. Immunol. 2014;33:314–329. doi: 10.3109/08830185.2014.917411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08830185.2014.917411</ArticleId>
            <ArticleId IdType="pmc">PMC4669348</ArticleId>
            <ArticleId IdType="pubmed">24892819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham M.W. Streptococcus and rheumatic fever. Curr. Opin. Rheumatol. 2012;24:408–416. doi: 10.1097/BOR.0b013e32835461d3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0b013e32835461d3</ArticleId>
            <ArticleId IdType="pmc">PMC3645882</ArticleId>
            <ArticleId IdType="pubmed">22617826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Lougee L., Dow S., Zamkoff J., Dubbert B.K. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am. J. Psychiatry. 1998;155:264–271. doi: 10.1176/foc.2.3.496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/foc.2.3.496</ArticleId>
            <ArticleId IdType="pubmed">9464208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Gerardi D.M., Parker-Athill E.C. The PANDAS Controversy: Why (and How) Is It Still Unsettled? Curr. Dev. Disord. Rep. 2014;1:236–244. doi: 10.1007/s40474-014-0025-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40474-014-0025-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E., Leonard H.L., Rapoport J.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: Separating fact from fiction. Pediatrics. 2004;113:907–911. doi: 10.1542/peds.113.4.907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.113.4.907</ArticleId>
            <ArticleId IdType="pubmed">15060242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiarello F., Spitoni S., Hollander E., Matucci Cerinic M., Pallanti S. An expert opinion on PANDAS/PANS: Highlights and controversies. Int. J. Psychiatry Clin. Pract. 2017;21:91–98. doi: 10.1080/13651501.2017.1285941.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/13651501.2017.1285941</ArticleId>
            <ArticleId IdType="pubmed">28498087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snider L.A., Swedo S.E. PANDAS: Current status and directions for research. Mol. Psychiatry. 2004;9:900–907. doi: 10.1038/sj.mp.4001542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4001542</ArticleId>
            <ArticleId IdType="pubmed">15241433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bodner S.M., Morshed S.A., Peterson B.S. The question of PANDAS in adults. Biol. Psychiatry. 2001;49:807–810. doi: 10.1016/S0006-3223(00)01127-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(00)01127-6</ArticleId>
            <ArticleId IdType="pubmed">11331090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carelli R., Pallanti S. Streptococcal infections of skin and PANDAS. Dermatol. Ther. 2014;27:28–30. doi: 10.1111/dth.12037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/dth.12037</ArticleId>
            <ArticleId IdType="pubmed">24502308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaspers-Fayer F., Han S.H.J., Chan E., McKenney K., Simpson A., Boyle A., Ellwyn R., Stewart S.E. Prevalence of Acute-Onset Subtypes in Pediatric Obsessive-Compulsive Disorder. J. Child Adolesc. Psychopharmacol. 2017;27:332–341. doi: 10.1089/cap.2016.0031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0031</ArticleId>
            <ArticleId IdType="pubmed">28121463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E., Rapoport J.L., Cheslow D.L., Leonard H.L., Ayoub E.M., Hosier D.M., Wald E.R. High prevalence of obsessive-compulsive symptoms in patients with Sydenham’s chorea. Am. J. Psychiatry. 1989;146:246–249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2912267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E. Sydenham’s chorea: A model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272:1788–1791. doi: 10.1001/jama.1994.03520220082035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.1994.03520220082035</ArticleId>
            <ArticleId IdType="pubmed">7661914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilbert D.L., Kurlan R. PANDAS: Horse or zebra? Neurology. 2009;73:1252–1253. doi: 10.1212/WNL.0b013e3181beed27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0b013e3181beed27</ArticleId>
            <ArticleId IdType="pubmed">19794126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Oliveira S.K., Pelajo C.F. Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection (PANDAS): A Controversial Diagnosis. Curr. Infect. Dis. Rep. 2010;12:103–109. doi: 10.1007/s11908-010-0082-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11908-010-0082-7</ArticleId>
            <ArticleId IdType="pubmed">21308506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E., Leckman J.F., Rose N.R. From research subgroup to clinical syndrome: Modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome) Pediatr. Ther. 2012;2:113. doi: 10.4172/2161-0665.1000113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4172/2161-0665.1000113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Parker-Athill E.C., Lewin A.B., Storch E.A., Mutch P.J. Cefdinir for recent-onset pediatric neuropsychiatric disorders: A pilot randomized trial. J. Child Adolesc. Psychopharmacol. 2015;25:57–64. doi: 10.1089/cap.2014.0010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2014.0010</ArticleId>
            <ArticleId IdType="pmc">PMC4340343</ArticleId>
            <ArticleId IdType="pubmed">25299463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jadah R.H.S., Mujeeb A.A. Neuropsychiatric symptoms following sore throat in a young boy. BMJ Case Rep. 2019;12:1–4. doi: 10.1136/bcr-2018-227540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2018-227540</ArticleId>
            <ArticleId IdType="pmc">PMC6347921</ArticleId>
            <ArticleId IdType="pubmed">30674494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoekstra P.J., Minderaa R.B. Tic disorders and obsessive-compulsive disorder: Is autoimmunity involved? Int. Rev. Psychiatry. 2005;17:497–502. doi: 10.1080/02646830500382003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02646830500382003</ArticleId>
            <ArticleId IdType="pubmed">16401548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernstein G.A., Victor A.M., Pipal A.J., Williams K.A. Comparison of clinical characteristics of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and childhood obsessive-compulsive disorder. J. Child Adolesc. Psychopharmacol. 2010;20:333–340. doi: 10.1089/cap.2010.0034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2010.0034</ArticleId>
            <ArticleId IdType="pmc">PMC3678581</ArticleId>
            <ArticleId IdType="pubmed">20807071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calkin C.V., Carandang C.G. Certain eating disorders may be a neuropsychiatric manifestation of PANDAS: Case report. J. Can. Acad. Child Adolesc. Psychiatry. 2007;16:132–135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2247422</ArticleId>
            <ArticleId IdType="pubmed">18421369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Kurlan R., Leckman J. The immunobiology of Tourette’s disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: A way forward. J. Child Adolesc. Psychopharmacol. 2010;20:317–331. doi: 10.1089/cap.2010.0043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2010.0043</ArticleId>
            <ArticleId IdType="pmc">PMC4003464</ArticleId>
            <ArticleId IdType="pubmed">20807070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calaprice D., Tona J., Parker-Athill E.C., Murphy T.K. A Survey of Pediatric Acute-Onset Neuropsychiatric Syndrome Characteristics and Course. J. Child Adolesc. Psychopharmacol. 2017;27:607–618. doi: 10.1089/cap.2016.0105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0105</ArticleId>
            <ArticleId IdType="pubmed">28140619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giulino L., Gammon P., Sullivan K., Franklin M., Foa E., Maid R., March J.S. Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? J. Child Adolesc. Psychopharmacol. 2002;12:157–164. doi: 10.1089/104454602760219199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/104454602760219199</ArticleId>
            <ArticleId IdType="pubmed">12188984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin H., Williams K.A., Katsovich L., Findley D.B., Grantz H., Lombroso P.J., Kingb R.A., Bessenc D.E., Johnsond D., Kaplan E.L., et al.  Streptococcal Upper Respiratory Tract Infections and Psychosocial Stress Predict Future Tic and Obsessive-Compulsive Symptom Severity in Children and Adolescents with Tourette Syndrome and Obsessive-Compulsive Disorder. Biol. Psychiatry. 2010;67:684–691. doi: 10.1016/j.biopsych.2009.08.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2009.08.020</ArticleId>
            <ArticleId IdType="pmc">PMC2843763</ArticleId>
            <ArticleId IdType="pubmed">19833320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orlovska S., Vestergaard C.H., Bech B.H., Nordentoft M., Vestergaard M., Benros M.E. Association of Streptococcal Throat Infection with Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study. JAMA Psychiatry. 2017;74:740–746. doi: 10.1001/jamapsychiatry.2017.0995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2017.0995</ArticleId>
            <ArticleId IdType="pmc">PMC5710247</ArticleId>
            <ArticleId IdType="pubmed">28538981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams K.A., Swedo S.E. Post-infectious autoimmune disorders: Sydenham’s chorea, PANDAS and beyond. Brain Res. 2015;1617:144–154. doi: 10.1016/j.brainres.2014.09.071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2014.09.071</ArticleId>
            <ArticleId IdType="pubmed">25301689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perrin E.M., Murphy M.L., Casey J.R., Pichichero M.E., Runyan D.K., Miller W.C., Snider L.A., Swedo S.E. Does group a beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch. Pediatr. Adolesc. Med. 2004;158:848–856. doi: 10.1001/archpedi.158.9.848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archpedi.158.9.848</ArticleId>
            <ArticleId IdType="pubmed">15351749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Snider L.A., Mutch P.J., Harden E., Zaytoun A., Edge P.J., Storch E.A., Yang M.C., Mann G., Goodman W.K., et al.  Relationship of Movements and Behaviors to Group A Streptococcus Infections in Elementary School Children. Biol. Psychiatry. 2007;61:279–284. doi: 10.1016/j.biopsych.2006.08.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2006.08.031</ArticleId>
            <ArticleId IdType="pubmed">17126304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Delgar B., Morer A., Luber M.J., Coffey B.J. Obsessive-compulsive disorder, tics, and autoinflammatory diseases: Beyond PANDAS. J. Child Adolesc. Psychopharmacol. 2016;26:847–850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6445174</ArticleId>
            <ArticleId IdType="pubmed">27854543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thienemann M., Murphy T., Leckman J., Shaw R., Williams K., Kapphahn C., Frankovich J., Geller D., Bernstein G., Chang K., et al.  Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I—Psychiatric and Behavioral Interventions. J. Child Adolesc. Psychopharmacol. 2017;27:566–573. doi: 10.1089/cap.2016.0145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0145</ArticleId>
            <ArticleId IdType="pmc">PMC5610394</ArticleId>
            <ArticleId IdType="pubmed">28722481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang K., Frankovich J., Cooperstock M., Cunningham M.W., Latimer M.E., Murphy T.K., Pasternack M., Thienemann M., Williams K., Walter J., et al.  Clinical Evaluation of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference. J. Child Adolesc. Psychopharmacol. 2015;25:3–13. doi: 10.1089/cap.2014.0084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2014.0084</ArticleId>
            <ArticleId IdType="pmc">PMC4340805</ArticleId>
            <ArticleId IdType="pubmed">25325534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sen E.S., Ramanan A.V. How to use antistreptolysin O titre. Arch. Dis. Child Educ. Pract. Ed. 2014;99:231–238. doi: 10.1136/archdischild-2013-304884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/archdischild-2013-304884</ArticleId>
            <ArticleId IdType="pubmed">24482289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delice S. Detection of anti- DNase B antibody upper normal values in children’s age groups who were admitted to hospital with noninfectious reasons. North Clin. Istanbul. 2015;2:136–141. doi: 10.14744/nci.2015.39358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14744/nci.2015.39358</ArticleId>
            <ArticleId IdType="pmc">PMC5175091</ArticleId>
            <ArticleId IdType="pubmed">28058354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen J.F., Bertille N., Cohen R., Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis (Review) Cochrane Database Syst. Rev. 2016;7:CD010502.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6457926</ArticleId>
            <ArticleId IdType="pubmed">27374000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katz B.Z. Streptococcal Infections and Exacerbations in Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection: A Systematic Review and Meta-Analysis. Pediatr. Infect. Dis. J. 2019;38:e190–e191. doi: 10.1097/INF.0000000000002310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000002310</ArticleId>
            <ArticleId IdType="pubmed">31306405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frick L., Pittenger C. Microglial Dysregulation in OCD, Tourette Syndrome, and PANDAS. J. Immunol. Res. 2016;2016:1–8. doi: 10.1155/2016/8606057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/8606057</ArticleId>
            <ArticleId IdType="pmc">PMC5174185</ArticleId>
            <ArticleId IdType="pubmed">28053994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zibordi F., Zorzi G., Carecchio M., Nardocci N. CANS: Childhood acute neuropsychiatric syndromes. Eur. J. Paediatr. Neurol. 2018;22:316–320. doi: 10.1016/j.ejpn.2018.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejpn.2018.01.011</ArticleId>
            <ArticleId IdType="pubmed">29398245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giedd J.N., Rapoport J.L., Garvey M.A., Perlmutter S., Swedo S.E. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am. J. Psychiatry. 2000;157:281–283. doi: 10.1176/appi.ajp.157.2.281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/appi.ajp.157.2.281</ArticleId>
            <ArticleId IdType="pubmed">10671403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giedd J.N., Rapoport J.L., Kruesi M.J., Parker C., Schapiro M.B., Allen A.J., Leonard H.L., Kaysen D., Dickstein D.P., Marsch W.L., et al.  Sydenham’s chorea: Magnetic resonance imaging of the basal ganglia. Neurology. 1996;45:2199–2202. doi: 10.1212/WNL.45.12.2199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.45.12.2199</ArticleId>
            <ArticleId IdType="pubmed">8848193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frick L.R., Rapanelli M., Jindachomthong K., Grant P., Leckman J.F., Swedo S., Williams K., Pittenger C. Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum. Brain Behav. Immun. 2018;69:304–311. doi: 10.1016/j.bbi.2017.12.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2017.12.004</ArticleId>
            <ArticleId IdType="pmc">PMC5857467</ArticleId>
            <ArticleId IdType="pubmed">29233751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tay T.L., Bechade C., D’Andrea I., St-Pierre M.K., Henry M.S., Roumier A., Tremblay M.E. Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan. Front. Mol. Neurosci. 2018;4:421. doi: 10.3389/fnmol.2017.00421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2017.00421</ArticleId>
            <ArticleId IdType="pmc">PMC5758507</ArticleId>
            <ArticleId IdType="pubmed">29354029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quagliariello A., Del Chierico F., Russo A., Reddel S., Conte G., Lopetuso L.R., Ianiro G., Dallapiccola B., Cardona F., Gasbarrini A., et al.  Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Front. Microbiol. 2018;9:1–15. doi: 10.3389/fmicb.2018.00675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2018.00675</ArticleId>
            <ArticleId IdType="pmc">PMC5900790</ArticleId>
            <ArticleId IdType="pubmed">29686658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celik G.G., Tas D.A., Tahiroglu A.Y., Erken E., Seydaoglu G., Ray P.C., Avci A. Mannose-Binding Lectin2 gene polymorphism in PANDAS patients. Noro Psikiyatri Arsivi. 2018;56:99–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6563857</ArticleId>
            <ArticleId IdType="pubmed">31223240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luleyap H., Onatoglu D., Yilmaz M., Alptekin D., Tahiroglu A., Cetiner S., Pazarbasi A., Unal I., Avci A., Comertpay G. Association between pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections disease and tumor necrosis factor- gene-308 g/a, -850 c/t polymorphisms in 4-12-year-old children in Adana/Turkey. Indian J. Hum. Genet. 2013;19:196. doi: 10.4103/0971-6866.116116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0971-6866.116116</ArticleId>
            <ArticleId IdType="pmc">PMC3758727</ArticleId>
            <ArticleId IdType="pubmed">24019622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris-Berry C.M., Pollard M., Gao S., Thompson C., Singer H.S. Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: Single-point and longitudinal assessments. J. Neuroimmunol. 2013;264:106–113. doi: 10.1016/j.jneuroim.2013.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2013.09.010</ArticleId>
            <ArticleId IdType="pubmed">24080310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macerollo A., Martino D. Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): An Evolving Concept. Tremor Other Hyperkinetic Mov. 2013;3 doi: 10.7916/D8ZC81M1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7916/D8ZC81M1</ArticleId>
            <ArticleId IdType="pmc">PMC3783973</ArticleId>
            <ArticleId IdType="pubmed">24106651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hesselmark E., Bejerot S. Biomarkers for diagnosis of Pediatric Acute Neuropsychiatric Syndrome (PANS)-Sensitivity and specificity of the Cunningham Panel. J. Neuroimmunol. 2017;312:31–37. doi: 10.1016/j.jneuroim.2017.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2017.09.002</ArticleId>
            <ArticleId IdType="pubmed">28919236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snider L.A., Lougee L., Slattery M., Grant P., Swedo S.E. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol. Psychiatry. 2005;57:788–792. doi: 10.1016/j.biopsych.2004.12.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2004.12.035</ArticleId>
            <ArticleId IdType="pubmed">15820236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Brennan E.M., Johnco C., Parker-Athill E.C., Miladinovic B., Storch E.A., Lewin A.B. A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive-Compulsive Disorder. J. Child Adolesc. Psychopharmacol. 2017;27:640–651. doi: 10.1089/cap.2016.0190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0190</ArticleId>
            <ArticleId IdType="pubmed">28358599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aman M., Rettiganti M., Nagaraja H.N., Hollway J.A., Mccracken J., Mcdougle C.J., Tierney E., Scahill L., Arnold L.E., Hellings J., et al.  Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial. J. Child Adolesc. Psychopharmacol. 2015;25:482–493. doi: 10.1089/cap.2015.0005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2015.0005</ArticleId>
            <ArticleId IdType="pmc">PMC4545698</ArticleId>
            <ArticleId IdType="pubmed">26262903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elia J., Dell M.L., Friedman D.F., Zimmerman R.A., Balamuth N., Ahmed A.A., Pati S. PANDAS with catatonia: A case report. Therapeutic response to lorazepam and plasmapheresis. J. Am. Acad. Child Adolesc. Psychiatry. 2005;44:1145–1150. doi: 10.1097/01.chi.0000179056.54419.5e.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.chi.0000179056.54419.5e</ArticleId>
            <ArticleId IdType="pubmed">16239863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovacevic M., Grant P., Swedo S.E. Use of Intravenous Immunoglobulin in the Treatment of Twelve Youths with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections. J. Child Adolesc. Psychopharmacol. 2015;25:65–69. doi: 10.1089/cap.2014.0067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2014.0067</ArticleId>
            <ArticleId IdType="pmc">PMC4340809</ArticleId>
            <ArticleId IdType="pubmed">25658609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storch E.A., Murphy T.K., Geffken G.R., Mann G., Adkins J.J., Merlo L., Duke D., Munson M., Swaine Z., Goodman W.K. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: Findings from a preliminary waitlist controlled open trial. J. Am. Acad. Child Adolesc. Psychiatry. 2006;45:1171–1178. doi: 10.1097/01.chi.0000231973.43966.a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.chi.0000231973.43966.a0</ArticleId>
            <ArticleId IdType="pubmed">17003662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celik G., Taa D., Tahiroglu A., Avci A., Yuksel B., Cam P. Vitamin D deficiency in obsessive-compulsive disorder patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: A case control study. Noro Psikiyatri Arsivi. 2016;53:31–34. doi: 10.5152/npa.2015.8763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5152/npa.2015.8763</ArticleId>
            <ArticleId IdType="pmc">PMC5353234</ArticleId>
            <ArticleId IdType="pubmed">28360763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sigra S., Hesselmark E., Bejerot S. Treatment of PANDAS and PANS: A systematic review. Neurosci. Biobehav. Rev. 2018;86:51–65. doi: 10.1016/j.neubiorev.2018.01.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2018.01.001</ArticleId>
            <ArticleId IdType="pubmed">29309797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooperstock M.S., Swedo S.E., Pasternack M.S., Murphy T.K., Consortium F.T.P. Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part III-Treatment and Prevention of Infections. J. Child Adolesc. Psychopharmacol. 2017;27:594–606. doi: 10.1089/cap.2016.0151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore D.P. Neuropsychiatric aspects of Sydenham’s chorea: A comprehensive review. J. Clin. Psychiatry. 1996;57:407–414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9746449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winter G., Hart R.A., Charlesworth R.P.G., Sharpley C.F. Gut microbiome and depression: What we know and what we need to know. Rev. Neurosci. 2018;29:629–643. doi: 10.1515/revneuro-2017-0072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/revneuro-2017-0072</ArticleId>
            <ArticleId IdType="pubmed">29397391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hermann A., Walker R.H. Diagnosis and Treatment of Chorea Syndromes. Curr. Neurol. Neurosci. Rep. 2015;15:514. doi: 10.1007/s11910-014-0514-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11910-014-0514-0</ArticleId>
            <ArticleId IdType="pubmed">25620691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern J.S. Tourette’s syndrome and its borderland. Pract. Neurol. 2018;18:262–270. doi: 10.1136/practneurol-2017-001755.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/practneurol-2017-001755</ArticleId>
            <ArticleId IdType="pubmed">29636375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martino D., Ganos C., Pringsheim T.M. Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics. Int. Rev. Neurobiol. 2017;134:1461–1490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28805580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hallett M. Tourette Syndrome: Update. Brain Dev. 2015;37:651–655. doi: 10.1016/j.braindev.2014.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.braindev.2014.11.005</ArticleId>
            <ArticleId IdType="pmc">PMC4475482</ArticleId>
            <ArticleId IdType="pubmed">25604739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cavanna A.E., Black K.J., Hallett M., Voon V. Neurobiology of the Premonitory Urge in Tourette’s Syndrome: Pathophysiology and Treatment Implications. J. Neuropsychiatry Clin. Neurosci. 2017;29:95–104. doi: 10.1176/appi.neuropsych.16070141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/appi.neuropsych.16070141</ArticleId>
            <ArticleId IdType="pmc">PMC5409107</ArticleId>
            <ArticleId IdType="pubmed">28121259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scharf J., Yu D., Huang A., Tsetsos F., Paschou P., Coppola G., Mathews C. Collaborative Genome-Wide Association and Copy Number Variation Analysis of Tourette Syndrome. Eur. Neuropsychopharmacol. 2019;29:S736–S737. doi: 10.1016/j.euroneuro.2017.06.064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.euroneuro.2017.06.064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirschtritt M.E., Darrow S.M., Illmann C., Osiecki L., Grados M., Sandor P., Dion Y., King R.A., Pauls D., Budman C.L., et al.  Genetic and phenotypic overlap of specific obsessive-compulsive and attention-deficit/hyperactive subtypes with Tourette syndrome. Psychol. Med. 2017;48:279–293. doi: 10.1017/S0033291717001672.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0033291717001672</ArticleId>
            <ArticleId IdType="pubmed">28651666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Church A.J. Tourettes syndrome: A cross sectional study to examine the PANDAS hypothesis. J. Neurol. Neurosurg. Psychiatry. 2003;74:602–607. doi: 10.1136/jnnp.74.5.602.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.74.5.602</ArticleId>
            <ArticleId IdType="pmc">PMC1738462</ArticleId>
            <ArticleId IdType="pubmed">12700302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spinello C., Laviola G., Macri S. Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourettes Syndrome in Preclinical Studies. Front. Neurosci. 2016;10:310. doi: 10.3389/fnins.2016.00310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2016.00310</ArticleId>
            <ArticleId IdType="pmc">PMC4928151</ArticleId>
            <ArticleId IdType="pubmed">27445678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suhs K.-W., Skripuletz T., Pul R., Alvermann S., Schwenkenbecher P., Stangel M., Muller-Vahl K. Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies. Mol. Brain. 2015;8:62. doi: 10.1186/s13041-015-0154-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13041-015-0154-6</ArticleId>
            <ArticleId IdType="pmc">PMC4604618</ArticleId>
            <ArticleId IdType="pubmed">26462472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oosterveer D.M., Overweg-Plandsoen W.C., Roos R.A. Sydenhams Chorea: A Practical Overview of the Current Literature. Pediatr. Neurol. 2010;43:1–6. doi: 10.1016/j.pediatrneurol.2009.11.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2009.11.015</ArticleId>
            <ArticleId IdType="pubmed">20682195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crealey M., Allen N.M., Webb D., Bouldin A., Sweeney N.M., Peake D., Tirupathi S., Butler K., King M.D. Sydenhams chorea: Not gone but perhaps forgotten. Arch. Dis. Child. 2015;100:1160–1162. doi: 10.1136/archdischild-2015-308693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/archdischild-2015-308693</ArticleId>
            <ArticleId IdType="pubmed">26374756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Goodman W.K., Ayoub E.M., Voeller K.K. On defining Sydenham’s chorea: Where do we draw the line? Biol. Psychiatry. 2000;47:851–857. doi: 10.1016/S0006-3223(00)00843-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-3223(00)00843-X</ArticleId>
            <ArticleId IdType="pubmed">10807957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker K.G., De Vries P.J., Stein D.J., Wilmshurst J.M. Sydenham chorea and PANDAS in South Africa: Review of evidence and recommendations for management in resource-poor countries. J. Child Neurol. 2015;30:850–859. doi: 10.1177/0883073814544704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0883073814544704</ArticleId>
            <ArticleId IdType="pubmed">25227516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris C.M., Pardo-Villamizar C., Gause C.D., Singer H.S. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J. Neurol. Sci. 2009;276:45–48. doi: 10.1016/j.jns.2008.08.032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2008.08.032</ArticleId>
            <ArticleId IdType="pubmed">18823914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gamucci A., Uccella S., Sciarretta L., D’Apruzzo M., Calevo M.G., Mancardi M.M., Veneselli E., De Grandis E. PANDAS and PANS: Clinical, Neuropsychological, and Biological Characterization of a Monocentric Series of Patients and Proposal for a Diagnostic Protocol. J. Child Adolesc. Psychopharmacol. 2019;29:305–312. doi: 10.1089/cap.2018.0087.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2018.0087</ArticleId>
            <ArticleId IdType="pubmed">30724577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehman M., Navarro V., Suchecki D., Handa R. Introduction to the PANS special issue. J. Neuroendocrinol. 2018;30:12612. doi: 10.1111/jne.12612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jne.12612</ArticleId>
            <ArticleId IdType="pubmed">29851206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frankovich J., Thienemann M., Rana S., Chang K. Five Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome of Differing Etiologies. J. Child Adolesc. Psychopharmacol. 2015;25:31–37. doi: 10.1089/cap.2014.0056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2014.0056</ArticleId>
            <ArticleId IdType="pmc">PMC4442568</ArticleId>
            <ArticleId IdType="pubmed">25695942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller N., Schwarz M.J. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert Rev. Neurother. 2006;6:1017–1038. doi: 10.1586/14737175.6.7.1017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14737175.6.7.1017</ArticleId>
            <ArticleId IdType="pubmed">16831116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hornig M. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr. Opin. Rheumatol. 2013;25:488–495. doi: 10.1097/BOR.0b013e32836208de.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0b013e32836208de</ArticleId>
            <ArticleId IdType="pubmed">23656715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morer A., Viñas O., Lázaro L., Bosch J., Toro J., Castro J. D8/17 Monoclonal Antibody: An Unclear Neuropsychiatric Marker. Behav. Neurol. 2005;16:1–8. doi: 10.1155/2005/795343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2005/795343</ArticleId>
            <ArticleId IdType="pmc">PMC5478839</ArticleId>
            <ArticleId IdType="pubmed">16082074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokol M.S., Ward P.E., Tamiya H., Kondo D.G., Houston D., Zabriskie J.B. D8/17 Expression on B Lymphocytes in Anorexia Nervosa. Am. J. Psychiatry. 2002;159:1430–1432. doi: 10.1176/appi.ajp.159.8.1430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/appi.ajp.159.8.1430</ArticleId>
            <ArticleId IdType="pubmed">12153841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bronze M.S., Dale J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J. Immunol. 1993;151:2820–2828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7689617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S.W., Grant J.E., Kim S.I., Swanson T.A., Bernstein G.A., Jaszcz W.B., Williams K.A., Schlievert P.M. A Possible Association of Recurrent Streptococcal Infections and Acute Onset of Obsessive-Compulsive Disorder. J. Neuropsychiatry Clin. Neurosci. 2004;16:252–260. doi: 10.1176/jnp.16.3.252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/jnp.16.3.252</ArticleId>
            <ArticleId IdType="pubmed">15377732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marazziti D., Albert U., Mucci F., Piccinni A. The Glutamate and the Immune Systems: New Targets for the Pharmacological Treatment of OCD. Curr. Med. Chem. 2018;25:5731–5738. doi: 10.2174/0929867324666171108152035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/0929867324666171108152035</ArticleId>
            <ArticleId IdType="pubmed">29119912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macri S., Spinello C., Widomska J., Magliozzi R., Poelmans G., Invernizzi R.W., Creti R., Roessner V., Bartolini E., Margarit I., et al.  Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice. Sci. Rep. 2018;8:1–12. doi: 10.1038/s41598-018-28372-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-28372-3</ArticleId>
            <ArticleId IdType="pmc">PMC6033871</ArticleId>
            <ArticleId IdType="pubmed">29976948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kipnis J., Cardon M., Avidan H., Lewitus G.M., Mordechay S., Rolls A., Shani Y., Schwartz M. Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: Implications for neurodegeneration. J. Neurosci. 2004;24:6133–6143. doi: 10.1523/JNEUROSCI.0600-04.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0600-04.2004</ArticleId>
            <ArticleId IdType="pmc">PMC6729670</ArticleId>
            <ArticleId IdType="pubmed">15240805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Besser M.J., Ganor Y., Levite M. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J. Neuroimmunol. 2005;169:161–171. doi: 10.1016/j.jneuroim.2005.07.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2005.07.013</ArticleId>
            <ArticleId IdType="pubmed">16150496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben-Pazi H., Stoner J.A., Cunningham M.W. Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham’s Chorea. PLoS ONE. 2013;8:e73516.  doi: 10.1371/journal.pone.0073516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0073516</ArticleId>
            <ArticleId IdType="pmc">PMC3779221</ArticleId>
            <ArticleId IdType="pubmed">24073196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravindran A.V., Griffiths J., Merali Z., Anisman H. Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. J. Affect. Disord. 1999;52:1–10. doi: 10.1016/S0165-0327(98)00072-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-0327(98)00072-X</ArticleId>
            <ArticleId IdType="pubmed">10357012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamothe H., Baleyte J.-M., Smith P., Pelissolo A., Mallet L. Individualized Immunological Data for Precise Classification of OCD Patients. Brain Sci. 2018;8:149.  doi: 10.3390/brainsci8080149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/brainsci8080149</ArticleId>
            <ArticleId IdType="pmc">PMC6119917</ArticleId>
            <ArticleId IdType="pubmed">30096863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Storch E.A., Lewin A.B., Edge P.J., Goodman W.K. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J. Pediatr. 2012;160:314–319. doi: 10.1016/j.jpeds.2011.07.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpeds.2011.07.012</ArticleId>
            <ArticleId IdType="pmc">PMC3227761</ArticleId>
            <ArticleId IdType="pubmed">21868033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levite M. Dopamine and T Cells: Dopamine Receptors and Potent Effects on T Cells, Dopamine Production in T Cells, and Abnormalities in the Dopaminergic System in T Cells in Autoimmune, Neurological and Psychiatric Diseases. Acta Physiol. 2016;216:42–89. doi: 10.1111/apha.12476.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apha.12476</ArticleId>
            <ArticleId IdType="pubmed">25728499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gruner P., Pittenger C. Cognitive inflexibility in Obsessive-Compulsive Disorder. Neuroscience. 2017;345:243–255. doi: 10.1016/j.neuroscience.2016.07.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2016.07.030</ArticleId>
            <ArticleId IdType="pmc">PMC5288350</ArticleId>
            <ArticleId IdType="pubmed">27491478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirvan C.A., Swedo S.E., Snider L.A., Cunningham M.W. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J. Neuroimmunol. 2006;179:173–179. doi: 10.1016/j.jneuroim.2006.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2006.06.017</ArticleId>
            <ArticleId IdType="pubmed">16875742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham M.W. Rheumatic fever revisited. Nat. Rev. Cardiol. 2014;11:123. doi: 10.1038/nrcardio.2012.197-c1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrcardio.2012.197-c1</ArticleId>
            <ArticleId IdType="pmc">PMC5967633</ArticleId>
            <ArticleId IdType="pubmed">24419260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hughes R., MedSci F., Bensa S., Willison H., Van Den Bergh P., Comi G., IIIa I., Nobile-Orazio E., van Doorn P., Dalakas M., et al.  Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 2001;50:195–201. doi: 10.1002/ana.1088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.1088</ArticleId>
            <ArticleId IdType="pubmed">11506402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kataoka Y., Kalanithi P.S.A., Grantz H., Schwartz M.L., Saper C., Leckman J.F., Vaccarino F.M. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J. Comp. Neurol. 2010;518:277–291. doi: 10.1002/cne.22206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.22206</ArticleId>
            <ArticleId IdType="pmc">PMC2846837</ArticleId>
            <ArticleId IdType="pubmed">19941350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonsi P., Cuomo D., Martella G., Madeo G., Schirinzi T., Puglisi F., Ponterio G., Pisani A. Centrality of Striatal Cholinergic Transmission in Basal Ganglia Function. Front. Neuroanat. 2011;5:6. doi: 10.3389/fnana.2011.00006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnana.2011.00006</ArticleId>
            <ArticleId IdType="pmc">PMC3036975</ArticleId>
            <ArticleId IdType="pubmed">21344017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S., Williams K.  PANDAS as a post-Streptococcal autoimmune neuropsychiatric form of OCD. In: Pittenger C., editor. Obsessive-Compulsive Disorder: Phenomenology, Pathophysiology, and Treatment. Oxford University Press; New York, NY, USA: 2017. pp. 311–321.</Citation>
        </Reference>
        <Reference>
          <Citation>Cox C.J., Sharma M., Leckman J.F., Zuccolo J., Zuccolo A., Kovoor A., Swedo S.E., Cunningham M.W. Brain Human Monoclonal Autoantibody from Sydenham Chorea Targets Dopaminergic Neurons in Transgenic Mice and Signals Dopamine D2 Receptor: Implications in Human Disease. J. Immunol. 2013;191:5524–5541. doi: 10.4049/jimmunol.1102592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1102592</ArticleId>
            <ArticleId IdType="pmc">PMC3848617</ArticleId>
            <ArticleId IdType="pubmed">24184556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sciamanna G., Napolitano F., Pelosi B., Bonsi P., Vitucci D., Nuzzo T., Punzo D., Ghiglieri V., Ponterio G., Pasqualetti M., et al.  Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons. Neurobiol. Dis. 2015;78:146–161. doi: 10.1016/j.nbd.2015.03.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2015.03.021</ArticleId>
            <ArticleId IdType="pubmed">25818655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremblay M., Stevens B., Sierra A., Wake H., Bessis A., Nimmerjahn A. The role of microglia in the healthy brain. J. Neurosci. 2011;31:16064–16069. doi: 10.1523/JNEUROSCI.4158-11.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4158-11.2011</ArticleId>
            <ArticleId IdType="pmc">PMC6633221</ArticleId>
            <ArticleId IdType="pubmed">22072657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du L., Zhang Y., Chen Y., Zhu J., Yang Y., Zhang H.L. Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target. Mol. Neurobiol. 2017;54:7567–7584. doi: 10.1007/s12035-016-0245-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-016-0245-0</ArticleId>
            <ArticleId IdType="pubmed">27830532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dileepan T., Smith E.D., Knowland D., Hsu M., Platt M., Bittner-Eddy P., Cohen B., Southern P., Latimer E., Harley E., et al.  Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells. J. Clin. Investig. 2016;126:303–317. doi: 10.1172/JCI80792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI80792</ArticleId>
            <ArticleId IdType="pmc">PMC4701547</ArticleId>
            <ArticleId IdType="pubmed">26657857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Husby G., Rijn I.D., Zabriskie J., Abdin Z., Williams R. Anti-Neuronal Antibody in Sydenhams Chorea. Lancet. 1977;309:1208. doi: 10.1016/S0140-6736(77)92749-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(77)92749-0</ArticleId>
            <ArticleId IdType="pubmed">68305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirvan C.A., Swedo S.E., Heuser J.S., Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 2003;9:914–920. doi: 10.1038/nm892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm892</ArticleId>
            <ArticleId IdType="pubmed">12819778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirvan C.A., Cox C.J., Swedo S.E., Cunningham M.W. Tubulin Is a Neuronal Target of Autoantibodies in Sydenham’s Chorea. J. Immunol. 2007;178:7412–7421. doi: 10.4049/jimmunol.178.11.7412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.178.11.7412</ArticleId>
            <ArticleId IdType="pubmed">17513792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirvan C.A., Swedo S.E., Kurahara D., Cunningham M.W. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenhams chorea. Autoimmunity. 2006;39:21–29. doi: 10.1080/08916930500484757.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08916930500484757</ArticleId>
            <ArticleId IdType="pubmed">16455579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman K.L. A Murine Model for Neuropsychiatric Disorders Associated with Group A -Hemolytic Streptococcal Infection. J. Neurosci. 2004;24:1780–1791. doi: 10.1523/JNEUROSCI.0887-03.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0887-03.2004</ArticleId>
            <ArticleId IdType="pmc">PMC6730451</ArticleId>
            <ArticleId IdType="pubmed">14973249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brimberg L., Benhar I., Mascaro-Blanco A., Alvarez K., Lotan D., Winter C., Klein J., Moses A.E., Somnier F.E., Leckman J.F. Behavioral, Pharmacological, and Immunological Abnormalities after Streptococcal Exposure: A Novel Rat Model of Sydenham Chorea and Related Neuropsychiatric Disorders. Neuropsychopharmacology. 2012;37:2076–2087. doi: 10.1038/npp.2012.56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/npp.2012.56</ArticleId>
            <ArticleId IdType="pmc">PMC3398718</ArticleId>
            <ArticleId IdType="pubmed">22534626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaddanapudi K., Hornig M., Serge R., Miranda J.D., Baghban A., Villar G., Lipkin W.I. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol. Psychiatry. 2009;15:712–726. doi: 10.1038/mp.2009.77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2009.77</ArticleId>
            <ArticleId IdType="pubmed">19668249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Church A.J., Dale R.C., Giovannoni G. Anti-basal ganglia antibodies: A possible diagnostic utility in idiopathic movement disorders? Arch. Dis. Child. 2004;89:611–614. doi: 10.1136/adc.2003.031880.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/adc.2003.031880</ArticleId>
            <ArticleId IdType="pmc">PMC1719969</ArticleId>
            <ArticleId IdType="pubmed">15210488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perlmutter S.J., Leitman S.F., Garvey M.A., Hamburger S., Feldman E., Leonard H.L., Swedo S.E. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 1999;354:1153–1158. doi: 10.1016/S0140-6736(98)12297-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(98)12297-3</ArticleId>
            <ArticleId IdType="pubmed">10513708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben-Pazi H., Sadan O., Offen D. Striatal Microinjection of Sydenham Chorea Antibodies: Using a Rat Model to Examine the Dopamine Hypothesis. J. Mol. Neurosci. 2012;46:162–166. doi: 10.1007/s12031-011-9559-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-011-9559-6</ArticleId>
            <ArticleId IdType="pubmed">21647711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lotan D., Benhar I., Alvarez K., Mascaro-Blanco A., Brimberg L., Frenkel D., Cunningham M.W., Joel D. Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats. Brain Behav. Immun. 2014;38:249–262. doi: 10.1016/j.bbi.2014.02.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2014.02.009</ArticleId>
            <ArticleId IdType="pmc">PMC4000697</ArticleId>
            <ArticleId IdType="pubmed">24561489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pavone P., Bianchini R., Parano E., Incorpora G., Rizzo R., Mazzone L., Trifiletti R.R. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr. Neurol. 2004;30:107–110. doi: 10.1016/S0887-8994(03)00413-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0887-8994(03)00413-2</ArticleId>
            <ArticleId IdType="pubmed">14984902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>da Rocha F.F., Correa H., Teixeira A.L. Obsessive-compulsive disorder and immunology: A review. Prog. Neuro Psychopharmacol. Biol. Psychiatry. 2008;32:1139–1146. doi: 10.1016/j.pnpbp.2007.12.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pnpbp.2007.12.026</ArticleId>
            <ArticleId IdType="pubmed">18262706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peterson B.S., Leckman J.F., Tucker D., Scahill L., Staib L., Zhang H., King R., Cohen D.J., Gore J.C., Lombroso P. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention- deficit/hyperactivity disorders. Arch. Gen. Psychiatry. 2000;57:364–372. doi: 10.1001/archpsyc.57.4.364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archpsyc.57.4.364</ArticleId>
            <ArticleId IdType="pubmed">10768698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rizzo R., Gulisano M., Pavone P., Fogliano F., Robertson M.M. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: Controlled cross-sectional study. J. Child Neurol. 2006;21:747–753. doi: 10.1177/08830738060210091001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/08830738060210091001</ArticleId>
            <ArticleId IdType="pubmed">16970879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cabrera B., Romero-Rebollar C., Jimenez-Angeles L., Genis-Mendoza A.D., Flores J., Lanzagorta N., Arroyo M., de la Fuente-Sandoval C., Santana D., Medina-Banuelos V., et al.  Neuroanatomical features and its usefulness in classification of patients with PANDAS. CNS Spectr. 2018;24:533–543. doi: 10.1017/S1092852918001268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1092852918001268</ArticleId>
            <ArticleId IdType="pubmed">30428956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snider L.A., Swedo S.E. Post-streptococcal Autoimmune Disorders of the Central Nervous System. Curr. Opin. Neurol. 2003;16:359–365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12858074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellini S., Fleming K.E., De M., McCauley J.P., Petroccione M.A., D’Brant L.Y., Tkachenko A., Kwon S., Jones L.A., Scimemi A. Neuronal Glutamate Transporters Control Dopaminergic Signaling and Compulsive Behaviors. J. Neurosci. 2018;38:937–961. doi: 10.1523/JNEUROSCI.1906-17.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1906-17.2017</ArticleId>
            <ArticleId IdType="pmc">PMC6596231</ArticleId>
            <ArticleId IdType="pubmed">29229708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stollerman G.H. Rheumatic Fever in the 21st Century. Clin. Infect. Dis. 2001;33:806–814. doi: 10.1086/322665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/322665</ArticleId>
            <ArticleId IdType="pubmed">11512086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham M.W. Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae. Gram Posit. Pathog. 2019;7:86–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6684244</ArticleId>
            <ArticleId IdType="pubmed">31373269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar A., Williams M.T., Chugani H.T. Evaluation of Basal Ganglia and Thalamic Inflammation in Children with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection and Tourette Syndrome: A Positron Emission Tomographic (PET) Study Using 11C-[R]-PK11. J. Child Neurol. 2015;30:749–756. doi: 10.1177/0883073814543303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0883073814543303</ArticleId>
            <ArticleId IdType="pubmed">25117419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malan-Muller S., Valles-Colomer M., Raes J., Lowry C.A., Seedat S., Hemmings S.M.J. The gut microbiome and mental health: Implications for anxiety- and trauma-related disorders. Omics J. Integr. Biol. 2018;22:90–107. doi: 10.1089/omi.2017.0077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/omi.2017.0077</ArticleId>
            <ArticleId IdType="pubmed">28767318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lach G., Schellekens H., Dinan T.G., Cryan J.F. Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. Neurotherapeutics. 2018;15:36–59. doi: 10.1007/s13311-017-0585-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13311-017-0585-0</ArticleId>
            <ArticleId IdType="pmc">PMC5794698</ArticleId>
            <ArticleId IdType="pubmed">29134359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gulas E., Wysiadecki G., Strzelecki D., Gawlik-Kotelnicka O., Polguj M. Can microbiology affect psychiatry? A link between gut microbiota and psychiatric disorders. Psychiatr. Pol. 2018;52:1023–1039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30659564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster J.A., McVey Neufeld K.A. Gut-brain axis: How the microbiome influences anxiety and depression. Trends Neurosci. 2013;36:305–312. doi: 10.1016/j.tins.2013.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tins.2013.01.005</ArticleId>
            <ArticleId IdType="pubmed">23384445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fowlie G., Cohen N., Ming X. The perturbance of microbiome and gut-brain axis in autism spectrum disorders. Int. J. Mol. Sci. 2018;19:2251.  doi: 10.3390/ijms19082251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19082251</ArticleId>
            <ArticleId IdType="pmc">PMC6121241</ArticleId>
            <ArticleId IdType="pubmed">30071612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seitz J., Trinh S., Herpertz-Dahlmann B. The Microbiome and Eating Disorders. Psychiatr. Clin. N. Am. 2019;42:93–103. doi: 10.1016/j.psc.2018.10.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psc.2018.10.004</ArticleId>
            <ArticleId IdType="pubmed">30704642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caputi V., Giron M.C. Microbiome-gut-brain axis and toll-like receptors in parkinson’s disease. Int. J. Mol. Sci. 2018;19:1689.  doi: 10.3390/ijms19061689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19061689</ArticleId>
            <ArticleId IdType="pmc">PMC6032048</ArticleId>
            <ArticleId IdType="pubmed">29882798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sochocka M., Donskow-Lysoniewska K., Diniz B.S., Kurpas D., Brzozowska E., Leszek J. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—A Critical Review. Mol. Neurobiol. 2019;56:1841–1851. doi: 10.1007/s12035-018-1188-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-018-1188-4</ArticleId>
            <ArticleId IdType="pmc">PMC6394610</ArticleId>
            <ArticleId IdType="pubmed">29936690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aarts E., Ederveen T.H.A., Naaijen J., Zwiers M.P., Boekhorst J., Timmerman H.M., Smeekens S.P., Netea M.G., Buitelaar J.K., Franke B., et al.  Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS ONE. 2017;12:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5581161</ArticleId>
            <ArticleId IdType="pubmed">28863139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanji S., Fonseka T.M., Marshe V.S., Sriretnakumar V., Hahn M.K., Muller D.J. The microbiome-gut-brain axis: Implications for schizophrenia and antipsychotic induced weight gain. Eur. Arch. Psychiatry Clin. Neurosci. 2018;268:3–15. doi: 10.1007/s00406-017-0820-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00406-017-0820-z</ArticleId>
            <ArticleId IdType="pubmed">28624847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leclercq S., Matamoros S., Cani P.D., Neyrinck A.M., Jamar F., Starkel P., Windey K., Trematoli V., Backhed F., Verbeke K., et al.  Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. USA. 2014;111:E4485–E4493. doi: 10.1073/pnas.1415174111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1415174111</ArticleId>
            <ArticleId IdType="pmc">PMC4210345</ArticleId>
            <ArticleId IdType="pubmed">25288760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gondalia S., Parkinson L., Stough C., Scholey A. Gut microbiota and bipolar disorder: A review of mechanisms and potential targets for adjunctive therapy. Psychopharmacology. 2019;236:1433–1443. doi: 10.1007/s00213-019-05248-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00213-019-05248-6</ArticleId>
            <ArticleId IdType="pubmed">31041459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y., Liu S., Shu H., Yanagisawa L., Tao F. Gut Microbiota Dysbiosis Enhances Migraine-Like Pain Via TNF Upregulation. Mol. Neurobiol. 2019;57:461–468. doi: 10.1007/s12035-019-01721-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-019-01721-7</ArticleId>
            <ArticleId IdType="pmc">PMC6980505</ArticleId>
            <ArticleId IdType="pubmed">31378003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milliken S., Allen R.M., Lamont R.F. The role of antimicrobial treatment during pregnancy on the neonatal gut microbiome and the development of atopy, asthma, allergy and obesity in childhood. Expert Opin. Drug Saf. 2019;18:173–185. doi: 10.1080/14740338.2019.1579795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14740338.2019.1579795</ArticleId>
            <ArticleId IdType="pubmed">30739516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jasarevic E., Howard C.D., Misic A.M., Beiting D.P., Bale T.L. Stress during pregnancy alters temporal and spatial dynamics of the maternal and offspring microbiome in a sex-specific manner. Sci. Rep. 2017;7:44182. doi: 10.1038/srep44182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep44182</ArticleId>
            <ArticleId IdType="pmc">PMC5339804</ArticleId>
            <ArticleId IdType="pubmed">28266645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelly J.R., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbiota axis: Challenges for translation in psychiatry. Ann. Epidemiol. 2016;26:366–372. doi: 10.1016/j.annepidem.2016.02.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annepidem.2016.02.008</ArticleId>
            <ArticleId IdType="pubmed">27005587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudzki L., Szulc A. Immune Gate of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders. Front. Psychiatry. 2018;9:205. doi: 10.3389/fpsyt.2018.00205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyt.2018.00205</ArticleId>
            <ArticleId IdType="pmc">PMC5987016</ArticleId>
            <ArticleId IdType="pubmed">29896124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lener M.S., Niciu M.J., Ballard E.D., Park M., Park L.T., Nugent A.C., Zarate C.A., Jr. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine. Biol. Psychiatry. 2017;81:886–897. doi: 10.1016/j.biopsych.2016.05.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2016.05.005</ArticleId>
            <ArticleId IdType="pmc">PMC5107161</ArticleId>
            <ArticleId IdType="pubmed">27449797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lydiard R.B. The role of GABA in anxiety disorders. J. Clin. Psychiatry. 2003;64(Suppl. 3):21–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12662130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romeo B., Choucha W., Fossati P., Rotge J.-Y. Meta-analysis of central and peripheral Y-aminobutyric acid levels in patients with unipolar and bipolar depression. J. Psychiatry Neurosci. 2018;43:58–66. doi: 10.1503/jpn.160228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1503/jpn.160228</ArticleId>
            <ArticleId IdType="pmc">PMC5747536</ArticleId>
            <ArticleId IdType="pubmed">29252166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freed R.D., Coffey B.J., Mao X., Weiduschat N., Kang G., Shungu D.C., Gabbay V. Decreased Anterior Cingulate Cortex Y-Aminobutyric Acid in Youth with Tourettes Disorder. Pediatr. Neurol. 2016;65:64–70. doi: 10.1016/j.pediatrneurol.2016.08.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pediatrneurol.2016.08.017</ArticleId>
            <ArticleId IdType="pubmed">27743746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gabbay V., Bradley K.A., Mao X., Ostrover R., Kang G., Shungu D.C. Anterior cingulate cortex Y-aminobutyric acid deficits in youth with depression. Transl. Psychiatry. 2017;7:e1216. doi: 10.1038/tp.2017.187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/tp.2017.187</ArticleId>
            <ArticleId IdType="pmc">PMC5611750</ArticleId>
            <ArticleId IdType="pubmed">28892070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiu P., Lui S.S., Hung K.S., Chan R.C., Chan Q., Sham P., Cheung E.F.C., Mak H.K.F. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study. Schizophr. Res. 2018;193:295–303. doi: 10.1016/j.schres.2017.07.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.schres.2017.07.021</ArticleId>
            <ArticleId IdType="pubmed">28751130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gubellini P., Pisani A., Centonze D., Bernardi G., Calabresi P. Metabotropic glutamate receptors and striatal synaptic plasticity: Implications for neurological diseases. Prog. Neurobiol. 2004;74:271–300. doi: 10.1016/j.pneurobio.2004.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pneurobio.2004.09.005</ArticleId>
            <ArticleId IdType="pubmed">15582223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherwin E., Sandhu K.V., Dinan T.G., Cryan J.F. May the Force Be with You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry. CNS Drugs. 2016;30:1019–1041. doi: 10.1007/s40263-016-0370-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40263-016-0370-3</ArticleId>
            <ArticleId IdType="pmc">PMC5078156</ArticleId>
            <ArticleId IdType="pubmed">27417321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez J.M., Murphy K., Stanton C., Ross R.P., Kober O.I., Juge N., Avershina E., Rudi K., Narbad A., Jenmalm M.C., et al.  The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 2015;26:26050. doi: 10.3402/mehd.v26.26050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3402/mehd.v26.26050</ArticleId>
            <ArticleId IdType="pmc">PMC4315782</ArticleId>
            <ArticleId IdType="pubmed">25651996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otoole P.W., Claesson M.J. Gut microbiota: Changes throughout the lifespan from infancy to elderly. Int. Dairy J. 2010;20:281–291. doi: 10.1016/j.idairyj.2009.11.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idairyj.2009.11.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aleman F.D.D., Valenzano D.R. Microbiome evolution during host aging. PLoS Pathog. 2019;15:e1007727.  doi: 10.1371/journal.ppat.1007727.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1007727</ArticleId>
            <ArticleId IdType="pmc">PMC6657895</ArticleId>
            <ArticleId IdType="pubmed">31344129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Derrien M., Alvarez A.-S., Vos W.M.D. The Gut Microbiota in the First Decade of Life. Trends Microbiol. 2019;27:997–1010. doi: 10.1016/j.tim.2019.08.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2019.08.001</ArticleId>
            <ArticleId IdType="pubmed">31474424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Becattini S., Taur Y., Pamer E.G. Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol. Med. 2016;22:458–478. doi: 10.1016/j.molmed.2016.04.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmed.2016.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC4885777</ArticleId>
            <ArticleId IdType="pubmed">27178527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy T.K., Storch E.A., Turner A., Reid J.M., Tan J., Lewin A.B. Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder. J. Neuroimmunol. 2010;229:243–247. doi: 10.1016/j.jneuroim.2010.08.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2010.08.017</ArticleId>
            <ArticleId IdType="pmc">PMC2991439</ArticleId>
            <ArticleId IdType="pubmed">20864184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Roak B.J., Morgan T.M., Fishman D.O., Saus E., Alonso P., Gratacos M., Estivill X., Teltsh O., Kohn Y., Kidd K.K., et al.  Additional support for the association of SLITRK1 var321 and Tourette syndrome. Mol. Psychiatry. 2010;15:447–450. doi: 10.1038/mp.2009.105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2009.105</ArticleId>
            <ArticleId IdType="pmc">PMC3292207</ArticleId>
            <ArticleId IdType="pubmed">20351724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian Y., Gunther J.R., Liao I.H., Liu D., Ander B.P., Stamova B.S., Lit L., Jickling G.C., Xu H., Zhan X., et al.  GABA- and acetylcholine-related gene expression in blood correlate with tic severity and microarray evidence for alternative splicing in Tourette syndrome: A pilot study. Brain Res. 2011;1381:228–236. doi: 10.1016/j.brainres.2011.01.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2011.01.026</ArticleId>
            <ArticleId IdType="pubmed">21241679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neth O., Jack D.L., Dodds A.W., Holzel H., Klein N.J., Turner M.W. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 2000;68:688–693. doi: 10.1128/IAI.68.2.688-693.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.68.2.688-693.2000</ArticleId>
            <ArticleId IdType="pmc">PMC97193</ArticleId>
            <ArticleId IdType="pubmed">10639434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Xu Z., Ou X., Wang M., Yang X., Li Q. Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children. Eur. J. Pediatr. 2009;168:1305–1313. doi: 10.1007/s00431-009-0924-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00431-009-0924-1</ArticleId>
            <ArticleId IdType="pubmed">19169708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomaa M.H., Ali S.S., Fattouh A.M., Hamza H.S., Badr M.M. MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: An Egyptian pilot study. Pediatr. Rheumatol. 2018;16:1–7. doi: 10.1186/s12969-018-0245-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12969-018-0245-x</ArticleId>
            <ArticleId IdType="pmc">PMC5899397</ArticleId>
            <ArticleId IdType="pubmed">29653582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blackburn J.S. Tic Disorders and PANDAS. Semin. Pediatr. Neurol. 2018;25:25–33. doi: 10.1016/j.spen.2017.12.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.spen.2017.12.003</ArticleId>
            <ArticleId IdType="pubmed">29735114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farhood Z., Ong A.A., Discolo C.M. PANDAS: A systematic review of treatment options. Int. J. Pediatr. Otorhinolaryngol. 2016;89:149–153. doi: 10.1016/j.ijporl.2016.08.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijporl.2016.08.008</ArticleId>
            <ArticleId IdType="pubmed">27619047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frankovich J. 23.3 Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Use of Immunomodulatory Therapies. J. Am. Acad. Child Adolesc. Psychiatry. 2017;56:S339. doi: 10.1016/j.jaac.2017.07.715.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaac.2017.07.715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown K.D., Farmer C., Freeman G.M., Spartz E.J., Farhadian B., Thienemann M., Frankovich J. Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic. J. Child Adolesc. Psychopharmacol. 2017;27:619–628.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5749580</ArticleId>
            <ArticleId IdType="pubmed">28696786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hesselmark E., Bejerot S. Patient Satisfaction and Treatments Offered to Swedish Patients with Suspected Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. J. Child Adolesc. Psychopharmacol. 2019;29:634–641. doi: 10.1089/cap.2018.0141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2018.0141</ArticleId>
            <ArticleId IdType="pmc">PMC6786336</ArticleId>
            <ArticleId IdType="pubmed">31009235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahapatra A., Panda P.K., Sagar R. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection treated successfully with a course of oral antibiotics. Asian J. Psychiatr. 2017;25:256–257. doi: 10.1016/j.ajp.2016.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajp.2016.12.013</ArticleId>
            <ArticleId IdType="pubmed">28262166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E., Frankovich J., Murphy T.K. Overview of Treatment of Pediatric Acute-Onset Neuropsychiatric Syndrome. J. Child Adolesc. Psychopharmacol. 2017;27:562–565. doi: 10.1089/cap.2017.0042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2017.0042</ArticleId>
            <ArticleId IdType="pmc">PMC5610386</ArticleId>
            <ArticleId IdType="pubmed">28722464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirschtritt M.E., Bloch M.H., Mathews C.A. Obsessive-Compulsive Disorder. JAMA. 2017;317:1358. doi: 10.1001/jama.2017.2200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2017.2200</ArticleId>
            <ArticleId IdType="pubmed">28384832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents with Obsessive-Compulsive Disorder. JAMA. 2004;292:1969. doi: 10.1001/jama.292.16.1969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.292.16.1969</ArticleId>
            <ArticleId IdType="pubmed">15507582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ost L.-G., Riise E.N., Wergeland G.J., Hansen B., Kvale G. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis. J. Anxiety Disord. 2016;43:58–69. doi: 10.1016/j.janxdis.2016.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.janxdis.2016.08.003</ArticleId>
            <ArticleId IdType="pubmed">27632568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demirkaya S.K., Demirkaya M., Yusufo_lu C., Akln E. Atomoxetine Use in Attention-Deficit/Hyperactivity Disorder and Comorbid Tic Disorder in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. J. Child Adolesc. Psychopharmacol. 2017;27:104–105. doi: 10.1089/cap.2016.0065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0065</ArticleId>
            <ArticleId IdType="pubmed">27315236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spartz E.J., Freeman G.M., Jr., Brown K., Farhadian B., Thienemann M., Frankovich J. Course of Neuropsychiatric Symptoms After Introduction and Removal of Nonsteroidal Anti-Inflammatory Drugs: A Pediatric Observational Study. J. Child Adolesc. Psychopharmacol. 2017;27:652–659. doi: 10.1089/cap.2016.0179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0179</ArticleId>
            <ArticleId IdType="pubmed">28696783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexander A.A.Z., Patel N.J., Southammakosane C.A., Mortensen M.M. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): An indication for tonsillectomy. Int. J. Pediatr. Otorhinolaryngol. 2011;75:872–873. doi: 10.1016/j.ijporl.2011.03.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijporl.2011.03.006</ArticleId>
            <ArticleId IdType="pubmed">21466900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Windfuhr J.P., Hilf K.M. Tonsillectomy remains a questionable option for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) GMS Curr. Top. Otorhinolaryngol. Head Neck Surg. 2016;15:110–115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5169080</ArticleId>
            <ArticleId IdType="pubmed">28025607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demesh D., Virbalas J.M., Bent J.P. The role of tonsillectomy in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) JAMA Otolaryngol. Head Neck Surg. 2015;141:272–275. doi: 10.1001/jamaoto.2014.3407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaoto.2014.3407</ArticleId>
            <ArticleId IdType="pubmed">25569020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilbur C., Bitnun A., Kronenberg S., Laxer R.M., Levy D.M., Logan W.J., Shouldice M., Yeh E.A. PANDAS/PANS in childhood: Controversies and evidence. Paediatr. Child Health. 2019;24:85–91. doi: 10.1093/pch/pxy145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/pch/pxy145</ArticleId>
            <ArticleId IdType="pmc">PMC6462125</ArticleId>
            <ArticleId IdType="pubmed">30996598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pavone P., Falsaperla R., Nicita F., Zecchini A., Battaglia C., Spalice A., Iozzi L., Parano E., Vitaliti G., Verrotti A., et al.  Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection (PANDAS): Clinical Manifestations, IVIG Treatment Outcomes, Results from a Cohort of Italian Patients. Neuropsychiatry. 2018;8:854–860. doi: 10.4172/Neuropsychiatry.1000412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4172/Neuropsychiatry.1000412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Latimer M.E., L’Etoile N., Seidlitz J., Swedo S.E. Therapeutic plasma apheresis as a treatment for 35 severely Ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J. Child Adolesc. Psychopharmacol. 2015;25:70–75. doi: 10.1089/cap.2014.0080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2014.0080</ArticleId>
            <ArticleId IdType="pmc">PMC4340509</ArticleId>
            <ArticleId IdType="pubmed">25658452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moretti G., Pasquini M., Mandarelli G., Tarsitani L., Biondi M. What every psychiatrist should know about PANDAS: A review. Clin. Pract. Epidemiol. Ment. Health. 2008;4:13. doi: 10.1186/1745-0179-4-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1745-0179-4-13</ArticleId>
            <ArticleId IdType="pmc">PMC2413218</ArticleId>
            <ArticleId IdType="pubmed">18495013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dale R. Autoimmunity and the basal ganglia: New insights into old diseases. QJM. 2003;96:183–191. doi: 10.1093/qjmed/hcg026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/hcg026</ArticleId>
            <ArticleId IdType="pubmed">12615982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singer H.S., Loiselle C.R., Lee O., Minzer K., Swedo S., Grus F.H. Anti-basal ganglia antibodies in PANDAS. Mov. Disord. 2004;19:406–415. doi: 10.1002/mds.20052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.20052</ArticleId>
            <ArticleId IdType="pubmed">15077238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yazici K.U., Percinel Yazici I., Ustundag B. Vitamin D levels in children and adolescents with obsessive-compulsive disorder. Nord. J. Psychiatry. 2018;72:173–178. doi: 10.1080/08039488.2017.1406985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08039488.2017.1406985</ArticleId>
            <ArticleId IdType="pubmed">29168423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stagi S., Lepri G., Rigante D., Cerinic M.M., Falcini F. Cross-Sectional Evaluation of Plasma Vitamin D Levels in a Large Cohort of Italian Patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. J. Child Adolesc. Psychopharmacol. 2018;28:124–129. doi: 10.1089/cap.2016.0159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cap.2016.0159</ArticleId>
            <ArticleId IdType="pubmed">29112476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boileau B. A review of obsessive-compulsive disorder in children and adolescents. Dialogues Clin. Neurosci. 2011;13:401–411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3263388</ArticleId>
            <ArticleId IdType="pubmed">22275846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centonze D., Gubellini P., Pisani A., Bernardi G., Calabresi P. Dopamine, Acetylcholine and Nitric Oxide Systems Interact to Induce Corticostriatal Synaptic Plasticity. Rev. Neurosci. 2003;14:207–216. doi: 10.1515/REVNEURO.2003.14.3.207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/REVNEURO.2003.14.3.207</ArticleId>
            <ArticleId IdType="pubmed">14513864</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
